Dyring, Charlotte «"Optimising the Drosophila S2 Expression System for Production of Therapeutic Vaccines"». BioProcessing Journal., 10(2), 2011, pàg. 28–35.[5]Arxivat 2022-09-02 a Wayback Machine.
nih.gov
pubmed.ncbi.nlm.nih.gov
Pamboukian MM, Jorge SA, Santos MG, Yokomizo AY, Pereira CA, Tonso A. «"Insect cells respiratory activity in bioreactor"». Cytotechnology, 57(1), 2008, pàg. 37–44.[3]
Moraes, Ângela M.; Jorge, Soraia A. C.; Astray, Renato M.; Suazo, Claudio A. T.; Calderón Riquelme, Camilo E.; Augusto, Elisabeth F. P.; Tonso, Aldo; Pamboukian, Marilena M.; Piccoli, Rosane A. M. «"Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development"». Biotechnology Advances, 30(3), 2012, pàg. 613–628.[4]
Fasbender, Frank; Claus, Maren; Wingert, Sabine; Sandusky, Mina; Watzl, Carsten «"Differential Requirements for Src-Family Kinases in SYK or ZAP70-Mediated SLP-76 Phosphorylation in Lymphocytes"». Frontiers in Immunology, 8), 2017, pàg. 789.[6]
silverchair-cdn.com
cob.silverchair-cdn.com
Schneider I «"Cell Lines Derived from Late Embryonic Stages of Drosophila melanogaster"». J. Embryol. Exp. Morphol., 27, 1972, pàg. 363–365.[1]Arxivat 2022-09-02 a Wayback Machine.
web.archive.org
Schneider I «"Cell Lines Derived from Late Embryonic Stages of Drosophila melanogaster"». J. Embryol. Exp. Morphol., 27, 1972, pàg. 363–365.[1]Arxivat 2022-09-02 a Wayback Machine.
Dyring, Charlotte «"Optimising the Drosophila S2 Expression System for Production of Therapeutic Vaccines"». BioProcessing Journal., 10(2), 2011, pàg. 28–35.[5]Arxivat 2022-09-02 a Wayback Machine.
wiley.com
onlinelibrary.wiley.com
.Adriana L. L. Galesi, Carlos A. Pereira, Ângela M. Moraes Dr. «"Culture of transgenic Drosophila melanogaster Schneider 2 cells in serum-free media based on TC100 basal medium"». Biotechnology J., 2(11), 2007, pàg. 1399-1407.[2]